Clinical Trial Update: Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

View source ↗

Summary

The Janssen Research & Development trial to assess treatment patterns in metastatic castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Prostatic Neoplasms | Status: COMPLETED